340B Unscripted
SpendMend Pharmacy
All episodes
Best episodes
Top 10 340B Unscripted Episodes
Goodpods has curated a list of the 10 best 340B Unscripted episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to 340B Unscripted for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite 340B Unscripted episode by adding your comments to the episode page.
07/07/24 • 74 min
In this episode, Greg and Rob gear up for the 340B Summer Coalition conference, and are joined again by Ted Slafsky to discuss various 340B developments from the first half of 2024. They’ll discuss the ongoing contract pharmacy saga between entities and manufacturers, debate the future of proposed federal legislation addressing 340B Program reform, and recap pertinent court cases with both direct and indirect impact on 340B.
In the intro, the guys catch up on updated contract pharmacy restrictions and recent audit experiences.
Come find us at Booth #717 at the 2024 340B Coalition Summer Conference!
Listeners are welcome to use code “SpendMend25” to receive a 25% discount for new subscriptions to 340B Report. Visit https://340breport.com/
Ep 53 | J&J 340B Rebate Model Follow-Up Discussion
340B Unscripted
09/23/24 • 52 min
In this episode, Greg and Rob catch up on developments surrounding the J&J 340B rebate proposal, including HRSA’s response. They’ll address some outstanding questions from the recent SpendMend webinar on the topic.
In the intro, they recap some updates regarding contract pharmacy litigation and thoughts on how DSCSA and product serialization data might impact 340B operations.
If you missed it before, you can watch our webinar on the J&J 340B rebate model here: https://ww2.spendmend.com/webinar-jj-340b-rebate-model-what-covered-entities-need-to-know/
Ep 47 | Alternate Distribution Models & 340B
340B Unscripted
06/17/24 • 55 min
In this episode, Greg and Rob are joined by a new SpendMend team member – Nick Gnadt – to discuss considerations around the use of alternate distribution models (ADMs) in the 340B space. They discuss some of the practical considerations around implementing ADM, where there may be operational or regulatory challenges, and what the long-term outlook is for this more novel strategy.
In the intro, the guys recap a flurry of updates in contract pharmacy restrictions, and discuss a communication posted on OPA’s website that foreshadows what might be an increasing number of HRSA audit reports released over the next few months that have findings of non-compliance.
Catch us at 340B Coalition Summer Conference July 8th - 10th in National Harbor. We will be at booth 717!
Ep 46 | Revisiting the Intersection of the IRA Medicare Drug Pricing Program & 340B – Conversation with Jeff Davis
340B Unscripted
06/03/24 • 53 min
In this episode, Greg and Rob welcome back health care attorney Jeff Davis to catch up on the latest draft guidance published by CMS to address IRA-mandated Medicare drug pricing provisions and impact to 340B providers (15:25). Additionally, they chat about the 340B ACCESS Act, a new piece of draft legislation introduced in the House with sweeping 340B Program reform considerations (41:28).
In the intro, the guys talk about the Congressional developments around legislation and an upcoming House Energy & Commerce subcommittee hearing called on the 340B Program, recap the D.C. Circuit Court of Appeals ruling related to manufacturer-implemented contract pharmacy restrictions, and make a case for why telling your 340B story is critical right now.
Reach out to us at [email protected] with questions, comments or if you would give us the privilege of helping you share your 340B story!
Ep 45 | Chevron Doctrine & 340B
340B Unscripted
05/22/24 • 54 min
In this episode, Greg and Rob are joined by healthcare attorney Ross Marguiles to discuss how a Supreme Court ruling on litigation in the fishing industry could have a major impact on the healthcare landscape. Ross provides background on Chevron deference, a 40-year judicial doctrine that allows courts to defer ruling to federal administrative agencies, and ponders what the ripple effects could be to the 340B community if SCOTUS overturns this long-standing rule.
In the intro, the guys catch up on state-level contract pharmacy legislation and share thoughts on some recent data published around the 340B Program.
Ep 43 | Getting to Know the HRSA DRL – DRL 8 Self-Disclosure Documentation and DRL 9 Medicaid Billing Information
340B Unscripted
04/22/24 • 51 min
In this episode, Greg and Rob continue to provide insights on the HRSA data request list. DRL #8 is self-disclosure documentation and DRL #9 is Medicaid billing information, which includes providing details regarding your CE’s listing on the Medicaid Exclusion File, as well as sample billing claim forms for physician-administered drugs and billing claim screenshots for retail dispenses.
In the intro, they recap state-level 340B legislation, discuss ongoing uncertainty around Medicare Advantage & Part B underpayment remedies, and also note some recent data published on drug shortages.
Rob and other folks from our team will be attending Asembia in Las Vegas from April 29 – May 2. Reach out to us if you want to connect there! Email us at [email protected]
Also, save the date for our next webinar, which will be on May 14, 2024 – We’ll be sharing tips on what covered entities should be doing to effectively self-audit their 340B Program operations!
Ep 29 | The Intersection Between the Inflation Reduction Act (IRA) & 340B – Conversation with Jeff Davis
340B Unscripted
09/25/23 • 69 min
In this episode, Greg and Rob are joined by healthcare attorney Jeff Davis, to discuss how the Medicare drug pricing provisions in the IRA will impact 340B providers. They’ll go over CMS billing modifier requirements (15:27), share opinions on the financial impact covered entities might experience (38:02), and how various legal challenges to the IRA by the pharma industry may play out (56:29). They also add some insights around CMS’s proposed Part B payment remedy (1:01:03).
In the intro, Rob catches Greg up on new manufacturer restrictions, and some recent HRSA audit experience related to interpreting data request list (DRL) revisions, and shares some commentary on the current House E&C subcommittee hearing on proposed drug shortage legislation.
Email us questions, thoughts, and ideas for podcast topics at [email protected]!
Ep 23 | 340B and the Medicare Cost Report
340B Unscripted
07/03/23 • 57 min
Greg and Rob break down the ins and outs of the Medicare Cost Report and the dos and don'ts of child site registrations. They also provide an update on contract pharmacy manufacturer restrictions and information on the upcoming 340B Coalition Conference. We also hear from our Producer Aiden and provide the secret password for your free 340B Unscripted t-shirt at the conference.
Ep 20 | 340B History Lesson – The Morford Letter
340B Unscripted
05/22/23 • 54 min
In this episode, Rob and Greg discuss an interesting piece of 340B history – the Morford letter (25:31). Rob shares his understanding of the origins of the letter and contemporary application of the letter as it relates to the recent debate around the 340B-eligible patient definition.
But first, the guys catch up on 340B news, including:
-A reminder of 340B protections offered under the 2022 Consolidated Appropriations Act (i.e., DSH attestation)
-Legislative updates from the House E&C health subcommittee bill mark-up session
-Updated manufacturer restrictions for contract pharmacies
To access a copy of the Morford Letter: http://content.spendmend.com/assets/Morford-Letter-1.26.01.pdf
Ep 54 | 340B Operations Discussion – “Clean Site” Locations
340B Unscripted
10/01/24 • 50 min
In this episode, Greg and Rob get back to 340B basics and have a conversation around the concept of “clean site” 340B-only locations. They discuss what “clean site” means in the world of 340B, what the benefits of the approach are, what some of the risks and obstacles are from a compliance perspective, and share some anecdotes from past experiences working with these types of 340B universes.
In the intro, the guys discuss a couple of recent developments – most notably, J&J's response to HRSA's enforcement letter regarding the proposed rebate model.
Register for our upcoming webinar "Revolutionizing Pharmacy Procurement: Unlocking Savings with Automated NDC Selection": https://attendee.gotowebinar.com/register/1835792334721804630?source=340BUnscripted
Show more best episodes
Show more best episodes
FAQ
How many episodes does 340B Unscripted have?
340B Unscripted currently has 60 episodes available.
What topics does 340B Unscripted cover?
The podcast is about Business and Podcasts.
What is the most popular episode on 340B Unscripted?
The episode title 'Ep 46 | Revisiting the Intersection of the IRA Medicare Drug Pricing Program & 340B – Conversation with Jeff Davis' is the most popular.
What is the average episode length on 340B Unscripted?
The average episode length on 340B Unscripted is 52 minutes.
How often are episodes of 340B Unscripted released?
Episodes of 340B Unscripted are typically released every 14 days.
When was the first episode of 340B Unscripted?
The first episode of 340B Unscripted was released on Jul 12, 2022.
Show more FAQ
Show more FAQ